{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-027079","form_type":"8-K","ticker":"RVPH","cik":"0001742927","company_name":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","filed_at":"2022-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.949399+00:00","generated_at":"2026-06-21T20:44:53.689519+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Shareholders elect all five director nominees and ratify Armanino as auditor at 2022 annual meeting","bullets":["All five nominees (Bhat, Saxena, Margolin, Patel, Funtleyder) elected; votes for ranged from 7.8M to 8.3M.","Ratification of Armanino LLP as auditor passed with 12,986,442 for, 11,054 against, 21,489 abstentions.","Broker non-votes were 4,702,220 on director elections and zero on auditor ratification.","Meeting held November 10, 2022; results filed November 14, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-027079","json":"https://secwatch.observer/filing/0001437749-22-027079.json","markdown":"https://secwatch.observer/filing/0001437749-22-027079.md","text":"https://secwatch.observer/filing/0001437749-22-027079.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1742927/000143774922027079/0001437749-22-027079-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1742927/000143774922027079/rvph20221111b_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T20:44:53.689519+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"05c3b557d1bddd5a3e80bb7374a59171e9780fd1","claim":"REVIVA PHARMACEUTICALS HOLDINGS, INC. shareholders approved Election of each of Laxminarayan Bhat, Parag Saxena, Richard Margolin, Purav Patel and Les Funtleyder as directors at the 2022-11-10 meeting.","evidence_excerpt":"1. The election of each of Laxminarayan Bhat, Parag Saxena, Richard Margolin, Purav Patel and Les Funtleyder as directors to hold office for a term of one year, until their successor is duly elected and qualified or they are otherwise unable to complete their term. The votes were cast for this matter as follows: Votes Broker Non- Nominees Votes For Withheld Votes Laxminarayan Bhat 8,305,931 10,834 4,702,220 Parag Saxena 7,787,682 529,083 4,702,220 Richard Margolin 8,306,224 10,541 4,702,220 Purav Patel 8,296,697 20,068 4,702,220 Les Funtleyder 8,306,214 10,551 4,702,220","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1742927/000143774922027079/0001437749-22-027079-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-11-10"}],"fact_type":"shareholder_vote"},{"claim_id":"3ef6f8a1dd865b0d795e95689be1877eafcd8ae3","claim":"REVIVA PHARMACEUTICALS HOLDINGS, INC. shareholders approved Ratification of the appointment of Armanino LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022 at the 2022-11-10 meeting.","evidence_excerpt":"2. The proposal to ratify the appointment of Armanino LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2022 was approved based upon the following votes: Votes For Votes Against Abstentions Broker Non-Votes 12,986,442 11,054 21,489 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1742927/000143774922027079/0001437749-22-027079-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-11-10"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}